Search Results - "IOANNIDES, Constantine G"

Phase I Clinical Trial of a HER-2/neu Peptide (E75) Vaccine for the Prevention of Prostate-Specific Antigen Recurrence in High-Risk Prostate Cancer Patients by HUEMAN, Matthew T, DEHQANZADA, Zia A, PONNIAH, Sathibalan, PEOPLES, George E, NOVAK, Thomas E, GURNEY, Jennifer M, WOLL, Michael M, RYAN, Gayle B, STORRER, Catherine E, FISHER, Christine, MCLEOD, David G, IOANNIDES, Constantine G

“…Purpose: The E75 peptide is an immunogenic peptide from the HER-2/ neu protein that is substantially expressed in prostate cancer. We are conducting a clinical…”
Get full text

Longterm Followup Assessment of a HER2/ neu Peptide (E75) Vaccine for Prevention of Recurrence in High-Risk Prostate Cancer Patients by Gates, Jeremy D., MD, Carmichael, Mark G., MD, Benavides, Linda C., MD, Holmes, Jarrod P., MD, Hueman, Matthew T., MD, Woll, Michael M., MD, Ioannides, Constantine G., PhD, Robson, Craig H., MD, McLeod, David G., MD, Ponniah, Sathibalan, MD, Peoples, George E., MD

“…Background E75 is an immunogenic peptide from the HER2/ neu protein that is expressed in prostate cancer. High-risk prostate cancer (HRPC) patients…”
Get full text

Folate receptor α: A storied past and promising future in immunotherapy by Clifton, Guy T., Sears, Alan K., Clive, Kevin S., Holmes, Jarrod P., Mittendorf, Elizabeth A., Ioannides, Constantine G., Ponniah, Sathibalan, Peoples, George E.

“…Folate receptor alpha (FR α) is a membrane-bound transport protein with several features which make it an attractive target for cancer immunotherapy. FR α is…”
Get full text

Adenovirus-mediated interleukin (IL)-24 immunotherapy for cancer by Ramesh, Rajagopal, Ioannides, Constantine G, Roth, Jack A, Chada, Sunil

“…Interleukin-24 (IL-24) is a member of the IL-10 cytokine family. IL-24, also known as melanoma differentiation associated gene 7 (mda-7), is a unique cytokine…”
Get more information